The Medicines Patent Pool (MPP) is a UN-backed international public health organisation dedicated to increasing access to essential medicines and health technologies in low- and middle-income countries. MPP works with partners to license these medicines and technologies through its innovative business model, encouraging the development of new formulations and the expansion of generic manufacturing markets.
Because nearly 2 billion people, more than a quarter of the world’s population, cannot access high-quality essential medicines.
In 2023 almost 40 million people across the world were living with HIV, and around 630,000 people died from HIV-related causes.
Between 2019 and 2022, annual mortality from hepatitis rose by 200,000 to 1.3 million. It will soon be the world's deadliest infectious disease.
An estimated 10.8 million people worldwide fell ill with tuberculosis in 2023, and 1.25 million people died from the condition.
Non-communicable diseases (NCDs) killed at least 43 million people in 2021, equivalent to 75% of global non-pandemic-related deaths.
In 2020, 800 women died every day from preventable causes related to pregnancy and childbirth, equivalent to one death every two minutes.
FEATURED
From sales of medicines to impact on peoples’ lives, the MPP’s work is a game-changer in the access to treatments space.
Key areas of particular interest to MPP’s work.
MPP’s work is made possible by its funders, enabling greater access to life-saving treatments worldwide.